Tuftsmedicalcenter.org

Center for the Evaluation of Value and Risk in Health at Tufts …

WEB6th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner. The Center for the Evaluation of Value and Risk in Health (CEVR) at …

Actived: 6 days ago

URL: https://cevr.tuftsmedicalcenter.org/

SPEC: The Tufts Medical Center Specialty Drug Evidence and …

WEBWelcome! Researchers at the Center for the Evaluation of Value and Risk in Health developed SPEC with the goal of quantifying commercial health plan behavior. …

Category: Health Go Health

Noah Lubowsky, MD Dr. Gerald J. and Dorothy R. Friedman …

WEBNoah Lubowsky, MD Dr. Gerald J. and Dorothy R. Friedman Fellow in Diabetes & Metabolism 2006 - 2008 . Education . Dr. Lubowsky earned his B.A. in Chemistry from …

Category: Health Go Health

Anastassios G. Pittas, MD MS Dr. Gerald J. and Dorothy R.

WEBAnastassios G. Pittas, MD MS Dr. Gerald J. and Dorothy R. Friedman Fellow in Diabetes & Metabolism 2000 - 2002 . Education . Dr. Pittas received his B.S. from the …

Category: Health Go Health

QALYs in 2018—Advantages and Concerns

WEBJama 2018;319 (24):2473. The quality-adjusted life-year (QALY) is a health metric some people love to hate. Concerns include that QALYs are not patient focused,1 …

Category: Health Go Health

Updating cost-effectiveness--the curious resilience of the $50,000 …

WEBFor more than two decades, the ratio of $50,000 per quality-adjusted life-year (QALY) gained by using a given health care intervention has played an important if …

Category: Health Go Health

The much-maligned ‘quality-adjusted life year’ is a vital tool for

WEBHealth policy circles have erupted in debate over a wonky administrative tool: the quality-adjusted life year and similar metrics to value and price drugs and other …

Category: Health Go Health

The societal perspective in cost-effectiveness analysis: ICER has …

WEBBy Josh Cohen, PhD, Deputy Director & Chief Science Officer. On January 31st, the Institute for Clinical and Economic Review (ICER) published its third value assessment …

Category: Health Go Health

How US commercial health plans are covering semaglutide …

WEBBy Daniel Enright, MS, Molly T. Beinfeld, MPH, and James D. Chambers, PhD, MPharm, MSc. August 17, 2023. Introduction. Two years after its approval, …

Category: Health Go Health

Variation in payer coverage of mavacamten (Camzyos) for …

WEBDate: August 9, 2023 Molly T. Beinfeld, MPH, Dan Enright, MS and Jason H. Wasfy, MD, MS, MPhil. In a significant milestone for patients with hypertrophic cardiomyopathy …

Category: Health Go Health